Give Kids a Chance Act of 2023
- Last Action
- 9/21/2023
Actions
- 2023-09-21Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2023-09-21Introduced in Senate
CRS Summary
As of 2023-09-21 (00)
Give Kids a Chance Act of 2023
This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.
Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.
The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.
Cosponsors (6)
- Marco Rubio (R-FL)
- Jeanne Shaheen (D-NH)
- Edward Markey (D-MA)
- Amy Klobuchar (D-MN)
- Chris Van Hollen (D-MD)
- Mike Braun (R-IN)
Subjects
- Cancer
- Child health
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Government studies and investigations
- Medical research
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.